RARE
Ultragenyx Pharmaceutical Inc. · Healthcare
President and CEO Emil D Kakkis sold $1.0M of Ultragenyx Pharmaceutical Inc.
Sold$1,003,400
$50.17Price
20,000Shares
−1%Stake
What RARE did after the filing
- The stock from Wed, Aug 7 close, $48.94
- +20.1%
- S&P 500, same days
- +10.1%
Measured over 30 trading days, to the Sep 19 close.
Traded Tue, Aug 6. Filed Wed, Aug 7, 2:48 PM ET, during the session. Returns use the Aug 7 close and the Sep 19 close. Not investment advice.